CNBC - Health
Trump tells Senate Republicans to send federal health insurance money 'directly to the people'
6 hours ago
Trump's deals with Eli Lilly, Novo Nordisk could broaden obesity drug access6 hours ago
Startup Omada Health to start prescribing GLP-1s, other obesity medications1 day ago
Here's how much weight loss drugs could cost under Trump's deals with Lilly, Novo2 days ago
Trump announces deal with Eli Lilly, Novo Nordisk to cut weight loss drug prices2 days ago
Eli Lilly to start late-stage trials on amylin obesity drug after promising data2 days ago
Healthy Returns: Pfizer, Novo Nordisk escalate bidding war over Metsera2 days ago
Metsera says Novo Nordisk's new bid is 'superior' to revised Pfizer offer3 days ago
Pfizer tops estimates, raises profit guidance even as sales fall4 days ago
Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war4 days ago
Where the blockbuster weight loss drug market stands today — and what's coming next6 days ago
'Trump effect' raises hopes for cannabis rally as investors bet on change6 days ago
Breast cancer drug stock Olema Pharmaceutical could more than double from here7 days ago
This biotech stock has jumped 50% in 3 months9 days ago
We're raising our Eli Lilly price target — what a difference a quarter makes9 days ago
Midi Health introducing testosterone therapy as demand from women spikes9 days ago
Eli Lilly blows past estimates, hikes guidance on Zepbound and Mounjaro sales9 days ago
Merck tops estimates on Keytruda strength and narrows profit outlook9 days ago
FDA to speed up approvals of biosimilars as Trump targets high drug costs9 days ago
Eli Lilly, Walmart to offer discounted retail option for obesity drug Zepbound10 days ago
CVS beats estimates, hikes guidance as insurance business improves10 days ago
Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery10 days ago
Healthy Returns: What to expect from Eli Lilly, Merck, AbbVie Q3 earnings11 days ago
Novartis CEO says firm has the firepower for big M&A deals: 'Can never be done'11 days ago
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill18 days ago
Why cattlemen say Trump Argentine beef import idea no solution for record prices18 days ago
Novo Nordisk chair and directors quit after boardroom rift18 days ago
Anthropic's Claude Life Sciences will give researchers an AI efficiency boost18 days ago
Eli Lilly, Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s19 days ago
Trump announces efforts to expand access to IVF drugs23 days ago
Genentech to sell flu pill directly to some consumers at a discount23 days ago
DuPont prepares to spinoff electronics. What investors get with the remaining firm23 days ago
Wells Fargo, Pfizer CEOs caution U.S. could lose out to China without innovation24 days ago
Abbott disappoints again: We're downgrading it and considering what to do next24 days ago
